Invention Grant
- Patent Title: Crystal modifications of elobixibat
-
Application No.: US15134583Application Date: 2016-04-21
-
Publication No.: US09701649B2Publication Date: 2017-07-11
- Inventor: Martin Bohlin , Erica Tjerneld , Andreas Vestermark , Ingvar Ymen
- Applicant: Elobix AB
- Applicant Address: SE Gothenburg
- Assignee: Elobix AB
- Current Assignee: Elobix AB
- Current Assignee Address: SE Gothenburg
- Agency: Fish & Richardson P.C.
- Priority: SE1350517 20130426
- Main IPC: C07D281/10
- IPC: C07D281/10 ; A61K31/554 ; C07D281/02
Abstract:
The present invention relates to crystal modifications of N-{(2R)-2-[({[3,3-dibutyl-7-(methyl-thio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl]oxy}acetyl)amino]-2-phenylethanolyl}glycine (elobixibat), more specifically crystal modifications I, IV, MeOH-1, EtOH-1, 1-PrOH-1 and 2-PrOH-1. The invention also relates to a process for the preparation of these crystal modifications and to a pharmaceutical composition comprising crystal modification IV.
Public/Granted literature
- US20160237049A1 CRYSTAL MODIFICATIONS OF ELOBIXIBAT Public/Granted day:2016-08-18
Information query
